Cargando…

OA31 Successes and challenges in harmonising 4 national Juvenile Idiopathic Arthritis cohorts: an example from CLUSTER consortium

INTRODUCTION/BACKGROUND: The CLUSTER consortium aims to identify biomarkers and strata that improve personalised treatments for JIA/JIA-uveitis. By bringing together knowledge and data, CLUSTER can conduct novel analyses in this rare, heterogeneous disease. Data harmonisation across existing JIA coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawson-Tovey, Saskia, Smith, Samantha, Geifman, Nophar, Shoop-Worrall, Stephanie, Ng, Sandra, Barnes, Michael, Wedderburn, Lucy, Hyrich, Kimme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515876/ http://dx.doi.org/10.1093/rap/rkac066.031

Ejemplares similares

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
por: Lawson-Tovey, Saskia, et al.
Publicado: (2023)

Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2020)

OA30 Genetic analysis of whole exome sequencing in a cohort of children with refractory JIA reveals genetic risk factors for rare juvenile diseases
por: Tordoff, Melissa, et al.
Publicado: (2022)

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2021)

OA35 Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England
por: Costello, Ruth, et al.
Publicado: (2022)

How common is remission in juvenile idiopathic arthritis: A systematic review
por: Shoop-Worrall, Stephanie J.W., et al.
Publicado: (2017)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2017)

Long‐Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2018)

Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective study
por: Hendry, Gordon J, et al.
Publicado: (2018)

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2020)

Is time a healer? How quality of life changes over time reported by parents of children and young people with juvenile idiopathic arthritis
por: Smith, Andrew D, et al.
Publicado: (2022)

P57 What are the outcomes of persistent oligoarthritis? A systematic review plan
por: Smith, Andrew, et al.
Publicado: (2022)

Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis
por: Wedderburn, Lucy R, et al.
Publicado: (2023)

OA32 Minimally invasive, ultrasound-guided tissue biopsies of synovial tissue in children with Juvenile Idiopathic Arthritis for research: a feasibility study
por: Bolton, C, et al.
Publicado: (2022)

Intra-articular corticosteroid injections in juvenile idiopathic arthritis
por: Carrasco, Roberto, et al.
Publicado: (2014)

OA02.06. Importance of drug authentication and standardization as per API with the example of Alpinia species
por: Nini, KG, et al.
Publicado: (2013)

OA01. 31. Role of agnikarma in degenerative disorder w.s.r. Avbahuka (Frozen shoulder) - case study
por: Kumar, Vaneet, et al.
Publicado: (2012)

Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis
por: Hyrich, Kimme L, et al.
Publicado: (2016)

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
por: Pesenacker, AM, et al.
Publicado: (2011)

OA01.03. Sample size and regions of principally achievable significance in cost effectiveness studies: an example of complementary medicine
por: Ostermann, T, et al.
Publicado: (2012)

YIM-O13. Development of novel protein biomarkers for the prediction of response to treatment in juvenile idiopathic arthritis
por: Palman, Jason, et al.
Publicado: (2014)

Juvenile-onset inflammatory arthritis: a study of adolescents’ beliefs about underlying cause
por: Cordingley, Lis, et al.
Publicado: (2012)

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
por: Mcerlane, Flora, et al.
Publicado: (2013)

Treatment prescribing patterns in a cohort of patients with juvenile idiopathic arthritis (JIA). Data from the childhood arthritis prospective study (CAPS)
por: Davies, Rebecca, et al.
Publicado: (2014)

Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?
por: Yasin, Shireena A, et al.
Publicado: (2014)

OA12 Grimey granulomas of sarcoidosis
por: Nagra, Deepak, et al.
Publicado: (2023)

OA09 Vertebral fractures on bisphosphonates
por: Walshe, William, et al.
Publicado: (2023)

OA34 Juvenile Sjogren’s Syndrome: the need for validated paediatric diagnostic criteria. A retrospective review from a tertiary rheumatology centre
por: Foley, Charlene, et al.
Publicado: (2022)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

OA16 A great imitator of scleroderma
por: Josè, Alexa, et al.
Publicado: (2022)

Agreement between Proxy and Adolescent Assessment of Disability, Pain, and Well-Being in Juvenile Idiopathic Arthritis
por: Lal, Sham D., et al.
Publicado: (2011)

Towards an Age-Phenome Knowledge-base
por: Geifman, Nophar, et al.
Publicado: (2011)

The age-phenome database
por: Geifman, Nophar, et al.
Publicado: (2012)

The Mouse Age Phenome Knowledgebase and Disease-Specific Inter-Species Age Mapping
por: Geifman, Nophar, et al.
Publicado: (2013)

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)()()
por: Davies, Rebecca, et al.
Publicado: (2016)

OA01.01. A case report on psoriasis
por: Supraja, R
Publicado: (2013)

OA01.19. Standardization of jalnimanjjan purisha pariksha
por: Uikey, Rajesh
Publicado: (2012)

OA01.09. Management of systolic hypertension with shirodhara
por: Tathed, Pankaj P., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_95k2bpe7toolc381fhn0nvisfc